Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

IVAX

M&A STATUS
10K-15K EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
3 INVESTMENTS
Description

Manufacturer and developer of generic pharmaceuticals and veterinary products. The company's activities include research, development, manufacturing and marketing of generic pharmaceuticals and veterinary products, enabling customers to have quality products.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Primary Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States

IVAX Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore IVAX‘s full profile, request access.

Request full access to PitchBook

IVAX Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 11-May-2005 000000000000000000 00000 Pharmaceuticals
000000 00000000000 29-Aug-1994 000000000000000000 00000 Medical Supplies 0000000 00000 00
McGaw Laboratories 05-Jan-1994 Merger/Acquisition 00000 Medical Supplies 0000000 00000 00
To view this company’s complete investment and acquisition history, request access »

IVAX Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 05-Jan-1994 000000000000000000 00000 Completed
  • 0000
To view this company’s complete exits history, request access »

IVAX Executive Team (1)

Name Title Board
Seat
Contact
Info
Phillip Frost MD Founder, Chief Executive Officer & Chairman